v" Ninety-two patients with hydrocephalus secondary to cysticercotic meningitis were followed for a mean period of 8 years 11 months. The mortality rate was 50%, with most patients dying within the first 2 years after cerebrospinal fluid (CSF) shunting. The prognosis was worse in females than in males. Multiple surgical procedures for shunt obstruction were necessary in half of the patients. Complications such as bacterial meningitis and shunt obstruction were more frequent in the patients who died than in those who survived. The follow-up data revealed that the clinical status was satisfactory in 78% of survivors and unsatisfactory in 22%. Spontaneous remission of the cysticercotic arachnoiditis, as shown by the CSF findings, occurred in only 18% of the cases. In most patients, arachnoiditis and positive immune reactions persisted unchanged even after several years. The results demonstrate the poor outcome of these patients and indicate the need for better medical and surgical therapy.
V
ENTRICULAR shunting is the most frequently performed operation at neurosurgical departments in countries where neurocysticercosis is endemic. Thirty percent of all patients with neurocysticercosis develop hydrocephalus secondary to chronic arachnoiditis (in 25.7% of cases), to intraventricular cysts (in 0.7%), or to meningeal fibrosis (in 3.8%). 9 Most patients with chronic arachnoiditis develop hydrocephalus and the combination is commonly considered a sign of a poor prognosisY ,~2
Despite its high prevalence and mortality in several countries, TM little is known about the long-term evolution of cysticercotic arachnoiditis and its frequent complication, hydrocephalus. In a longitudinal study, we analyzed the outcome of patients with hydrocephalus secondary to cysticercotic arachnoiditis after implantation of a ventricular shunt. In the same group, we studied the natural evolution of arachnoiditis in an attempt to define prognostic factors.
Clinical Material and Methods
During the 5 years from January, 1975, to December, 1979, 185 patients with hydrocephalus secondary to cysticercotic arachnoiditis were treated at our Institute. Diagnosis was confirmed by computerized tomography and analysis of cerebrospinal fluid (CSF) was obtained by lumbar puncture; a positive reaction to the complement fixation test for cysticercosis 5 was noted in all cases. All patients underwent placement of a ventricular shunt, and these 185 procedures constituted 63% of all shunt placements performed in the Department of Neurosurgery over that period. In May, 1986, patients who were not still being treated at the Institute were recalled either by telephone, mail, telegram, or personal contact; 92 patients (50%) could not be contacted and were excluded from the study. Treatment results in 93 patients were evaluated at that time. One patient had died in a car accident during the follow-up period and was excluded, leaving a final figure of 92 (50%) patients followed.
Patients were separated into two groups based on the long-term outcome: Group I included those patients who had died within the observation period, and Group II comprised those who were alive in May, 1986 . Factors that could influence prognosis, such as age, sex, results of initial and follow-up CSF analysis, type of shunting procedure, number of operations, and complications such as bacterial meningitis, were compared for each group.
Forty-four survivors had CSF samples analyzed at various times during the follow-up period, allowing a study of the evolution of CSF findings. At the time when these patients were managed (1975 to 1979) no drug treatment for cysticercosis was known; ~I thus, except for the occasional use of anti-inflammatory steroid medication, the disease followed its natural course. The analysis did not include CSF samples obtained from patients during episodes of bacterial meningitis as a complication of shunting so that only changes due to cysticercotic meningitis would be considered. As ventricular CSF has a different composition from that of CSF obtained by lumbar puncture, particularly in patients with arachnoiditis, 5-7 ventricular CSF samples obtained during surgery were not included in the study.
Values were expressed as means _ standard error, and statistical analysis was made with Student's t-test.
Results
Ninety-two patients were followed for a mean observation period of 107 months (total 4784 months). The patients' ages at the time of shunting varied from 6 to 76 years (mean 37 _+ 2 years). Forty-six patients (50%) were male and 46 (50%) were female. All patients had hydrocephalus and intracranial hypertension with inflammation. A positive immunological reaction for cysticercosis was found on CSF analysis, which also showed the following mean results: cells 88 +_ 11/cu mm, protein 217 _ 26 mg/dl, and glucose 42 _+ 7 mg/dl.
The different shunt valves implanted were: Hakim in 71 cases, Pudenz in 12 cases, Holter in eight cases, and Fuji in one case. Reoperation for shunt obstruction was necessary in 43 patients (47%), with some cases requiring two or three procedures for a total of 66 reoperations. Eleven patients ( 12 %) developed bacterial meningitis after surgery; of these, nine had a Hakim valve and two a Pudenz valve. At the end of the observation period (mean 8 years 11 months), 46 patients (50%) had died (Group I) and 46 patients (50%) were alive (Group II).
Study Groups
Group L Of the 46 patients who did not survive (Group I), 21 (46%) were male and 25 (54%) were female. Death occurred between 1 day and 99 months (mean 22 _+ 4 months) after shunting; 34 patients (79%) died in the first 2 years after shunting, 28 (61%) of whom died within the 1st year. Age at surgery ranged from 17 to 75 years (mean 41 + 2 years 
Postoperative Clinical Status
The 46 surviving patients were separated into two subgroups based on their clinical status at the end of the study. Subgroup A included patients in a good clinical condition, who were active and working, although they might have mild complaints. Subgroup B comprised patients with physical limitations who were not active, who were incapable of working, and who had serious neurological complaints. There were 36 patients in Subgroup A (78% of survivors, 39% of all patients in the series). Twenty-one were male and 15 female. Mean findings of CSF analysis during the fol10w-up period were: cells 67 _+ 13/cu mm, protein 167 _+ 41 mg/dl, and glucose 42 +_ 3 mg/dl. Subgroup B contained 10 patients (22% of survivors, 11% of all patients in the series). Three were male and seven female. Mean findings of CSF analysis during the follow-up period were: cells 119 _+ 38/cu ram, protein 350 _ 146 mg/dl, and glucose 40 + 6 mg]dl. Figure 1 shows the mean cell count and protein levels in CSF found yearly after the initial CSF study in 44 survivors. For most patients, inflammation and positive immune reaction persisted unchanged at the last CSF analysis, even 9 years after diagnosis. However, in seven cases (18%) normal CSF findings were finally achieved and these patients were considered to demonstrate a spontaneous remission of cysticercotic arachnoiditis. Of these patients, one was cured after 1 year, one after 2 years, one after 3 years, two after 6 years, and two after 9 years. Mean CSF findings in these seven cases were: cells 70 + 21/cu mm and protein 96 + 18 mg/dl (initial analysis), and cells 2 + l/eu mm and protein 18 + 12 mg/dl (final analysis). In the last CSF specimen taken, the complement fixation test for cysticercosis 6 was still positive in four cases and negative in three cases. 
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Discussion
Only half of all patients originally treated for hydrocephalus secondary to cysticercotic arachnoiditis at our institute could be followed over a long period because of several factors. Most patients with neurocysticercosis belong to a low socioeconomic population, and frequently change addresses; thus, it is difficult to maintain contact with them. Some live in rural areas distant from cities, where transportation is difficult. Some patients whose discomfort continues despite medical intervention abandon treatment. Finally, some with favorable results refuse to return to the hospital.
The peak incidence of cysticercotic arachnoiditis was between the third and fourth decades of life. The mean patient age at time of surgery was 41 years in those who died and 33 years in survivors. As with other forms of neurocysticercosis, 8 cysticercotic arachnoiditis affects males and females similarly; however, in general terms, prognosis is worse in females. The male:female ratio was 21:25 for patients who died. In survivors, the male:female ratio for an acceptable clinical condition was 21:15 and for a poor outcome it was 3:7. Thus, outcome was poor in 70% of females and in 52% of males, and satisfactory in 48% of males and in 30% of females (p < 0.005). This finding supports the view that in some forms of neurocysticercosis females react to the parasite with a more severe inflammatory response. 8 Fifty percent of patients died during the follow-up period, most of them during the 1st and 2nd years after shunting. When their CSF values were compared with those from patients who survived in a favorable clinical condition, a strong association between degree of inflammation and prognosis was found: cells 104 + 17/ cu mm and protein 225 +_ 36 mg/dl for patients who died versus cells 67 _+ 13/cu mm and protein 167 _+ 41 mg/dl for patients who survived in an acceptable clinical condition. However, the findings in the CSF from patients who survived in a poor clinical condition were similar to those in the CSF from patients who died.
